CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 96 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $219,000 | -62.1% | 43,959 | -3.8% | 0.00% | -100.0% |
Q4 2020 | $578,000 | +49.0% | 45,719 | +15.7% | 0.00% | 0.0% |
Q3 2020 | $388,000 | -14.9% | 39,506 | -13.8% | 0.00% | 0.0% |
Q2 2020 | $456,000 | +27.7% | 45,815 | +13.5% | 0.00% | 0.0% |
Q1 2020 | $357,000 | +13.3% | 40,349 | +18.0% | 0.00% | 0.0% |
Q4 2019 | $315,000 | +57.5% | 34,194 | +0.6% | 0.00% | – |
Q3 2019 | $200,000 | -46.2% | 33,984 | +9.7% | 0.00% | -100.0% |
Q2 2019 | $372,000 | +0.3% | 30,986 | +0.8% | 0.00% | 0.0% |
Q1 2019 | $371,000 | -5.4% | 30,743 | -1.7% | 0.00% | 0.0% |
Q4 2018 | $392,000 | +20.2% | 31,261 | +42.4% | 0.00% | 0.0% |
Q3 2018 | $326,000 | -10.4% | 21,948 | +1.4% | 0.00% | 0.0% |
Q2 2018 | $364,000 | -9.2% | 21,637 | +23.5% | 0.00% | 0.0% |
Q1 2018 | $401,000 | -10.1% | 17,513 | +1.5% | 0.00% | 0.0% |
Q4 2017 | $446,000 | +47.7% | 17,248 | -15.6% | 0.00% | 0.0% |
Q3 2017 | $302,000 | +6.7% | 20,448 | +1.0% | 0.00% | 0.0% |
Q2 2017 | $283,000 | -11.6% | 20,253 | +8.0% | 0.00% | 0.0% |
Q1 2017 | $320,000 | +74.9% | 18,753 | +5.5% | 0.00% | – |
Q4 2016 | $183,000 | +3.4% | 17,777 | +1.8% | 0.00% | – |
Q3 2016 | $177,000 | -8.8% | 17,458 | +1.2% | 0.00% | -100.0% |
Q2 2016 | $194,000 | -4.4% | 17,248 | +16.3% | 0.00% | 0.0% |
Q1 2016 | $203,000 | -27.2% | 14,834 | +0.8% | 0.00% | 0.0% |
Q4 2015 | $279,000 | +8.1% | 14,709 | +6.9% | 0.00% | 0.0% |
Q3 2015 | $258,000 | +31.6% | 13,754 | +4.4% | 0.00% | 0.0% |
Q2 2015 | $196,000 | – | 13,180 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |